Ultromics was founded in 2017 from the University of Oxford, and is now a global company transforming the healthcare industry through innovative AI solutions which empower clinicians to make fast, accurate decisions when diagnosing cardiovascular disease, the number one global killer.
Echocardiogram analysis can be variable and time-consuming. Our technology automates analysis and eliminates variability which can lead to a more accurate diagnosis and save clinician’s time. We are working with some of the biggest names in healthcare, including Mayo Clinic in the United States and the NHS in the United Kingdom.
We host software and deliver analysis remotely through the cloud. There is no software on site. This means you will always have the latest updates, and there are no maintenance fees or additional in-house equipment or resource needed.